ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1019

Outdoor Air Pollution and Systemic Lupus Erythematosus

George Stojan1, Anton Kvit2, Frank Curriero2 and Michelle Petri3, 1Johns Hopkins University, BALTIMORE, MD, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, 3Johns Hopkins University School of Medicine, Baltimore

Meeting: ACR Convergence 2020

Keywords: Disease Activity, Environmental factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Understanding the role of environmental exposures in the development of SLE and their association with SLE activity may help identify modifiable risk factors and potential etiological mechanisms. We hypothesized that changes in coarse particulate matter (PM10, < 10 micrometers in size), sulfur dioxide, carbon monoxide, lead, and nitrogen dioxide are predictive of organ specific flares in lupus.

Methods: 1628 patients who fulfill 4 of the 11 ACR or SLICC classification criteria for SLE were included in the analysis. The data ranged from 1999 to 2017. Maximum distance between visits was 110 days with 1-month time aggregation units. Disease activity was expressed as Physician Global Estimate (PGA), taken at every patient visit. A flare was defined as a PGA score increase of 1 point or more compared to the previous visit. Environmental and atmospheric data was obtained from the EPA, including PM10, sulfur dioxide, carbon monoxide, lead, and nitrogen dioxide. The average values of each factor 10 days prior to patient visit was calculated. Univariate and multivariate models were built in order to study the association of these variables with lupus disease activity. The models were adjusted for age, sex, income, county racial distribution, rural vs. urban patient residence, distance to highways, distance to airports, PM2.5, PM10, sulfur dioxide, carbon monoxide, lead, and nitrogen dioxide concentrations, temperature, humidity, barometric pressure, ozone concentration, and residual wind. Univariate and stepwise multivariate logistic regression was used to identify significant determinants associated with lupus flares. Regression was performed for each organ flare outcome. Regression inference was based on generalized estimating equations (GEE) to account for the time repeated outcomes.

Results: Increases in sulfur dioxide concentration were directly associated with rash (p< 0.01), joints (p< 0.001), and neurologic flares (p< 0.001), and inversely associated with renal flares (p< 0.001) in multivariate analyses. Lead concentration was directly associated with neurologic (p< 0.001) and pulmonary flares (p< 0.001), and indirectly associated with serositis (p< 0.001) and renal flares (p< 0.001) in multivariate analysis. Nitrogen dioxide was directly associated with rash (p< 0.001), joints (p< 0.001), serositis (p< 0.001), hematologic (p< 0.001), pulmonary (p< 0.001), and renal flares (p< 0.001) in multivariate analysis. PM10 and carbon monoxide had no significant associations in multivariate analysis.

Conclusion: There is a strong association between changes in nitrogen dioxide, sulfur dioxide, and lead concentrations 10 days prior to patient visit and organ specific lupus activity at the visit. Nitrogen dioxide is the only pollutant with a general association with all organ specific lupus flares.


Disclosure: G. Stojan, None; A. Kvit, None; F. Curriero, None; M. Petri, AbbVie, 5, Amgen, 5, AstraZeneca, 2, 5, BMS, 5, Decision Resources, 5, GSK, 2, 5, INOVA, 5, IQVIA, 5, Janssen, 5, Eli Lilly, 2, 5, Merck EMD Serono, 5, Sanofi Japan, 5, Thermofisher, 5, UCB, 5, Exagen, 2.

To cite this abstract in AMA style:

Stojan G, Kvit A, Curriero F, Petri M. Outdoor Air Pollution and Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/outdoor-air-pollution-and-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outdoor-air-pollution-and-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology